Cited 14 times in
Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.